Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneReach Biotechnology develops and commercializes advanced molecular diagnostic platforms—primarily based on nucleic acid amplification—for rapid pathogen detection across aquaculture, agriculture, food safety, veterinary medicine and human health. Their systems include portable point-of-care devices as well as high-throughput laboratory solutions. The company’s products have been adopted worldwide in both research and industry settings; clinical results focus on sensitivity/specificity of pathogen detection rather than drug efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneReach Biotechnology.